Albireo Pharma, Inc. (NASDAQ: ALBO) enrolled first in PEDFIC-1 Phase 3
Albireo Pharma, Inc. (ALBO) stock price escalated 0.55% to finalize at $33.13 throughout previous buying and selling session. A total of 0.07 million shares exchanged [...]
Albireo Pharma, Inc. (ALBO) stock price escalated 0.55% to finalize at $33.13 throughout previous buying and selling session. A total of 0.07 million shares exchanged [...]
MSA Safety Incorporated (NYSE: MSA) above +2.32% and ended at $86.27. The stock’s market capitalization arrived at $3.298B and total traded volume was 157,464 shares. [...]
Shares of Henry Schein, Inc. (NASDAQ: HSIC) closed the trading at a price of $69.72 with the positive change of +0.94%. In the past session [...]
Shares of Halozyme Therapeutics, Inc. (NASDQ: HALO) below -0.46% and ended at $19.52. The stock’s market capitalization arrived at $2.79B and total traded volume was [...]
Genomic Health, Inc. (NASDAQ: GHDX) closed to $30.93. Recent traded volume was 194,150 shares versus to it an average volume of 1.093B shares. The stock’s [...]
Shares of Esperion Therapeutics, Inc. (NASDQ: ESPR) below -3.84% and ended at $66.43. The stock’s market capitalization arrived at $1.76B and total traded volume was [...]